VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $988,000 | +45.9% | 42,500 | 0.0% | 0.03% | +40.0% |
| Q1 2018 | $677,000 | +14.4% | 42,500 | +49.1% | 0.02% | +17.6% |
| Q4 2017 | $592,000 | +59100.0% | 28,500 | +47400.0% | 0.02% | – |
| Q3 2016 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 60 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -95.5% | 60 | -86.2% | 0.00% | -100.0% |
| Q4 2015 | $44,000 | -43.6% | 435 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $78,000 | -12.4% | 435 | +8.8% | 0.00% | 0.0% |
| Q2 2015 | $89,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |